H
Humata Health
Creating frictionless prior authorizations for payers and providers with AI and automation
About Humata Health
Humata Health provides a focused business-to-business solution for the healthcare industry, specifically targeting the complex and often manual process of prior authorizations. The company operates by deploying its proprietary artificial intelligence and automation platform to create a more seamless workflow for both healthcare providers and insurance payers. Revenue is generated by offering this end-to-end technology to its clients, which include over 225 hospitals and 42,000 physicians.
Read full description
Founded in 2023 by Dr. Jeremy Friese, Humata Health emerged from the founder's direct experience with the inefficiencies of the prior authorization system. Dr. Friese, a former interventional radiologist and physician executive at Mayo Clinic, previously founded Verata Health, another AI company focused on prior authorization that was acquired by Olive in 2020. Following the shutdown of Olive AI, Humata Health acquired its prior authorization business, augmenting its own proprietary technology. This journey reflects a persistent effort to solve a significant pain point in healthcare administration.
The company's core service is an AI-driven platform that automates the prior authorization process from start to finish. It integrates bi-directionally with common electronic health record (EHR) systems. When a provider orders a procedure, the platform first determines if an authorization is necessary. Using machine learning, it then automatically gathers, indexes, and bundles the precise clinical documentation required by the patient's health plan and the specific procedure. The system flags potential reasons for denial and can submit the completed clinical package with a single click. After submission, the platform automatically monitors the status and only requires human intervention if a denial or peer-to-peer review is necessary. A key achievement has been the implementation of "touchless" prior authorizations, where over 70% of requests for certain procedures were approved without any staff involvement after the initial order.
In June 2024, Humata Health secured a $25 million Series A funding round. The round was led by Blue Venture Fund and LRVHealth, with participation from other strategic investors including Optum Ventures, Highmark Ventures, and .406 Ventures. This capital is intended to further develop the company's generative AI technologies and expand its partnerships with both providers and payers, positioning the firm to meet the increased demand for efficiency driven by new CMS mandates for faster authorization decisions. Keywords: prior authorization automation, healthcare revenue cycle management, RCM, clinical documentation, payer-provider connectivity, medical billing AI, utilization management, EHR integration, healthcare administration, generative AI in healthcare, touchless authorizations, Jeremy Friese, Verata Health, Blue Venture Fund, LRVHealth, Optum Ventures, Highmark Ventures, Allegheny Health Network, medical pre-certification, claims denial prevention
At a glance
- Status
- Operational
- Founded
- 2017
- Headquarters
- Columbus, United States
- Employees
- 100
- Open positions
- 7
- Dealroom signal
- 91.6/100
- Industry
- Health, Fintech
- Sub-industry
- Health Platform, Payments
- Sector
- Health Tech & Medtech, Core AI, Health Insurance, Tech for Hospitals and Clinics, LandH Insurance, AI Applications
- Technology
- Artificial Intelligence
- Business model
- SaaS
- Client focus
- b2b
Latest news
Press, funding announcements and product moves mentioning Humata Health.
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITION✓Exit | Aug 2026 | $0 | — | R1 RCM | ↗ |
| EARLY VC✓Equity / VC | Jun 2024 | $25M | $100M | RaiSE SG · Highmark Ventures · LRVHealth · .406 Ventures | ↗ |
Growth signals
Latest recorded traffic for Humata Health is 4.2K monthly website visits, down 12.5% over the last three months. Humata Health's team grew 23.5% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A6 investors entered at this stage
LRVHealth
Blue Venture Fund- RSRaiSE SG
Highmark Ventures
.406 Ventures
Optum Ventures
Other known investors1 additional known investor
R1 RCM
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Humata Health on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Humata Health’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







